Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price target lifted by analysts at JPMorgan Chase & Co. from $51.00 to $53.00 in a research note issued to investors on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback